An open-label, uncontrolled trial of the angiotensin-converting enzyme inhibitor cilazapril in the treatment of patients with chronic congestive heart failure

Current Therapeutic Research - Clinical and Experimental

Volumn 58, Issue 9, 1997, Pages 594-600

  Demirel, Seref ^a   Akkaya, Vakur ^a   Dinç, Cengiz ^a   Sözen, Ahmet Bilge ^a   Metin, Gökhan ^b   Kudat, Hasan ^a   Ünal, Mehmet ^a   Yücebir, Ilker ^a   Tükek, Tufan ^a   Yazici, Ayten ^a   Beyaz, Mehmet ^a   Kayserilioǧlu, Abidin ^a   Korkut, Ferruh ^a   Ozlu, Evren ^c  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c Roche Müstahzarlari Sanayi A S   (Turkey)

Author keywords

Angiotensin converting enzyme inhibitor; Cilazapril; Heart failure

Indexed keywords

CILAZAPRIL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ADULT; AGED; ANAEROBIC THRESHOLD; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DRUG SAFETY; ECHOCARDIOGRAPHY; EXERCISE; FEMALE; HEART RATE; HUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; STATISTICS;

EID: 9844247558     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(97)80086-0     Document Type: Article

References (16)

1. The CONSENSUS Trial Study Group. Effect of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). NEJM. 1987;316:1429-1435.
2. Lilly L, Dzau VJ, Williams GH, et al. Captopril vs hydralazine in advanced congestive heart failure: Comparison of one year survival. Circulation. 1985;72(Suppl 3):408. Abstract.
3. Chalmers JP, West MJ, Cyran J, et al. Placebo-controlled study of lisinopril in congestive heart failure: A multicenter study. J Cardiovasc Pharmacol. 1987;9(Suppl 3):89-97.
4. Riegger GAJ. Results of long-term therapy with the angiotensin converting enzyme inhibitor quinapril in patients with congestive heart failure. Circulation. 1987;76(Suppl 4):178. Abstract.
5. Crozier IG, Ikram H, Nicolls MG, et al. Acute hemodynamic, hormonal and electrolyte effects of ramipril in severe congestive heart failure. Am J Cardiol. 1987;59(Suppl D): 155D-161D.
6. Dösseger L, Aldor E, Baird MG, et al. The effect of angiotensin converting enzyme inhibitors on exercise performance and clinical symptoms in chronic heart failure: A multicenter, double blind, placebo-controlled study. Eur Heart J. 1993;14(Suppl C):18-23.
7. Declaration of Helsinki. Recommendations Guiding Physicians in Biomedical Research Involving Human Subjects. 41st World Medical Assembly, Hong Kong, September 1989.
8. Zohman LR, Young JL, Kattus AA. Treadmill walking protocol for the diagnostic evaluation and exercise programming of cardiac patients. Am J Cardiol. 1993;51:1081-1085.
9. Henry WL, DeMarie A, Gramiak R, et al. Report of the American Society of Echocardiography Committee on nomenclature and standards in two dimensional echocardiography. Circulation. 1980;62:212-220.
10. Sahn DJ, DeMaria A, Kisslo J, Weyman A. Recommendations regarding quantitation in M Mode echocardiography: Results of a survey of echocardiographic measurements. Circulation. 1978;58:1072-1083.
11. Zelis R, Sinoway LI, Musch TI, et al. Regional blood flow in congestive heart failure: Concept of compensatory mechanism with short and long time constants. Am J Cardiol. 1988;62(Suppl E):2E-8E.
12. Drexler H, Hiroi M, Riede U, et al. Skeletal muscle blood flow, metabolism and morphology in chronic congestive heart failure and effects of short- and long-term angiotensin-converting enzyme inhibition. Am J Cardiol. 1988;62(Suppl E):49E-52E.
13. Saxena PR, Schoemaker RG. Organ blood flow protection in hypertension and congestive heart failure. Am J Med. 1993;94(Suppl 4A):4A-4S.
14. McKirnan MD, Sullivan M, Jensen DG, et al. Limitations in the clinical assessment of functional capacity and its relationship to ventricular function in coronary patients. Med Sci Sports Exerc. 1982;14:438. Abstract.
15. Benge W, Litchfield RL, Marcus MD. Exercise capacity in patients with severe left ventricular dysfunction. Circulation. 1980;61:955-960.
16. Weber MA, Drayer JIM, Baird WM. Echocardiographic evaluation of left ventricular hypertrophy. J Cardiovasc Pharmacol. 1986;8(Suppl 3):S61-S69.